Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-06-04
1994-04-05
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514254, 540575, 544360, 544362, 544365, 546119, 546120, 546315, 546335, A61K 3155, A61K 31495, C07D47104
Patent
active
053004981
ABSTRACT:
There are disclosed various compounds of the formula below, ##STR1## where the parameters n, R.sub.1, R.sub.2 and X are as defined in the specification which are selective inhibitors of the reuptake of the serotonin and as such are useful for the treatment of depression and obsessive compulsive disorder.
REFERENCES:
patent: 3925388 (1975-12-01), Hoehn et al.
patent: 4020072 (1977-04-01), Hoehn
M. K. A. Ibrahim et al., J. Indian Chem. Soc., vol. 64, 345-347 (1987).
Bernhardt Emily
Hoechst-Roussel Pharmaceuticals Incorporated
Ikeda Tatsuya
LandOfFree
6-piperazinyl-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acids, est does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-piperazinyl-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acids, est, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-piperazinyl-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acids, est will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-511128